In last trading session, scPharmaceuticals Inc (NASDAQ:SCPH) saw 0.69 million shares changing hands with its beta currently measuring 0.38. Company’s recent per share price level of $3.87 trading at -$0.11 or -2.76% at ring of the bell on the day assigns it a market valuation of $204.30M. That closing price of SCPH’s stock is at a discount of -45.99% from its 52-week high price of $5.65 and is indicating a premium of 49.87% from its 52-week low price of $1.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 382.72K if we extend that period to 3-months.
For scPharmaceuticals Inc (SCPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
scPharmaceuticals Inc (NASDAQ:SCPH) trade information
Upright in the red during last session for losing -2.76%, in the last five days SCPH remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $3.87 price level, adding 3.97% to its value on the day. scPharmaceuticals Inc’s shares saw a change of -2.27% in year-to-date performance and have moved 0.78% in past 5-day. scPharmaceuticals Inc (NASDAQ:SCPH) showed a performance of 8.10% in past 30-days. Number of shares sold short was 1.83 million shares which calculate 4.01 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 70.23% to its current value. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 13. It follows that stock’s current price would drop -235.92% in reaching the projected high whereas dropping to the targeted low would mean a loss of -235.92% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -1.52% during past 5 years.
scPharmaceuticals Inc (NASDAQ:SCPH)’s Major holders
Insiders are in possession of 6.08% of company’s total shares while institution are holding 76.64 percent of that, with stock having share float percentage of 81.60%. Investors also watch the number of corporate investors in a company very closely, which is 76.64% institutions for scPharmaceuticals Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at SCPH for having 5.56 million shares of worth $24.18 million. And as of 2024-06-30, it was holding 14.2608 of the company’s outstanding shares.
The second largest institutional holder is RUBRIC CAPITAL MANAGEMENT LP, which was holding about 3.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.042 of outstanding shares, having a total worth of $15.33 million.
